.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Progress and Promise in Advanced Pancreatic Cancer

EP. 1: Systemic Therapy in Newly Diagnosed Pancreatic Cancer

February 15th 2016

EP. 2: Deciding Among Frontline Standards of Care in Pancreatic Cancer

February 15th 2016

EP. 3: Dose Modification Rationale in Advanced Pancreatic Cancer

February 15th 2016

EP. 4: Clinical Trial Results of MM-398 in Pancreatic Cancer

February 15th 2016

EP. 5: Impact of MM-398 on Sequencing Decisions in Pancreatic Cancer

February 15th 2016

EP. 6: QOL Considerations in Advanced Pancreatic Cancer

February 15th 2016

EP. 7: Role of Surgery in Locally Advanced Pancreatic Cancer

February 15th 2016

EP. 8: Neoadjuvant Therapy in Resectable Pancreatic Cancer

February 15th 2016

EP. 9: Advanced Pancreatic Cancer: Options in the Adjuvant Setting

February 15th 2016

EP. 10: Emerging Immunotherapy Data in Pancreatic Cancer

February 15th 2016

EP. 11: Molecular Profiling in Pancreatic Cancer

February 15th 2016

EP. 12: Early Phase Clinical Trials in Pancreatic Cancer

February 15th 2016

EP. 13: Advanced Pancreatic Cancer: A Look Ahead

February 15th 2016